New therapy aims to beat depression relapse

NCT ID NCT06183359

Recruiting now Symptom relief Sponsor: University Hospital, Montpellier Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new type of talk therapy called Correct Self-Identification Program for people with major depression. 86 adults will be randomly assigned to either this new therapy or a standard therapy (ACT). The goal is to see if the new therapy reduces depression symptoms more and prevents relapse for 6 months after treatment ends.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: talk therapy (Correct Self-Identification Program)
What this could lead to: If it works, this could offer a more effective talk therapy option for people with depression, potentially reducing symptoms and preventing relapse.
What could go wrong: This is a small, early pilot study with only 86 participants, so results may not apply to everyone. It's also comparing two types of therapy, so the difference might be small or not meaningful.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Depression major depressive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MAJOR DEPRESSIVE DISORDER THIRD WAVE COGNITIVE BEHAVIORAL THERAPY

Contacts and locations

Locations

CHU Montpellier
RECRUITING

Montpellier, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.